Get the Stockscreener App
0.65
5.93%
-0.041
After Hours:
.68
0.03
+4.62%
Tela Bio Inc stock is traded at $0.65, with a volume of 24,697.
It is down -5.93% in the last 24 hours and down -7.88% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$0.691
Open:
$0.68
24h Volume:
24,697
Relative Volume:
0.17
Market Cap:
$29.10M
Revenue:
$80.28M
Net Income/Loss:
$-38.83M
P/E Ratio:
-0.7814
EPS:
-0.8318
Net Cash Flow:
$-28.67M
1W Performance:
-9.73%
1M Performance:
-7.88%
6M Performance:
-33.67%
1Y Performance:
-66.15%
1-Day Range:
$0.6116
$0.7008
1-Week Range:
$0.6116
$0.7998
52-Week Range:
$0.5011
$2.1399
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.65 | 30.93M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
TELA Bio Sets Aug. 10 Earnings Call and Business Update - MyChesCo
TELA Bio Inc (TELA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TELA Bio Inc (TELA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
TELA|TELA Bio Inc|Price:0.691|Chg%:-0.020 - TradingKey
TELA Bio Inc (TELA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Liquifix earns exclusive FDA approval for inguinal and femoral hernia adhesive, TELA Bio launches - Traders Union
TELA Bio to announce second quarter 2026 financial results on August 10 - scanx.trade
TELA Bio to Announce Second Quarter 2026 Financial Results - The Manila Times
TELA Bio sets Aug. 10 webcast for second-quarter update - Stock Titan
Form 4 Tela Bio Inc For: 17 July By Investing.com - Investing.com Nigeria
TELA Bio (TELA) awards director 6,227 fully vested compensation shares - Stock Titan
TELA Bio advances hernia repair through innovation in medical science - Traders Union
TELA Stock Price, Quote & Chart - ChartMill
TELA Bio Q1 2026 Earnings: EPS Misses Estimates; Stock Edges HigherReturn On Capital - dars.gov.et
TELATELA Bio Inc Dividends - Finviz
TELA Bio Inc. (TELA) Shows Modest Uptick as Stock Tests Key ResistanceVolume Weighted Price - DonanımHaber
TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA) - TradingView
TELA Bio, Inc. Actuals & Estimates (BOATS:TELA) - TradingView
TELA Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to earnings forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to sales forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
TELA Bio Inc (TELA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TELA Bio Inc (TELA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TELA Bio Inc (TELA) Institutional Confidence - TradingKey
TELA Bio Inc. (TELA) Slides 5.7% as Shares Approach Critical Support at $0.82Volatility Breakout Picks - newsline.com
TELA Bio (TELA) grants director new RSUs and stock options - Stock Titan
TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options - Stock Titan
TELA Bio (NASDAQ: TELA) grants director new stock and options - Stock Titan
Joseph H. Capper joins TELA Bio (TELA) board and files initial insider report - Stock Titan
TELA Bio (TELA) director awarded 11,675 shares and options for 17,335 - Stock Titan
Director Guido J. Neels files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
TELA Bio : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership - Stock Titan
TELA Bio (TELA) director Paul Thomas receives RSU and option grants - Stock Titan
Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Shareholders Expand Equity Incentive Plan Authorization - TipRanks
TELA Bio (NASDAQ: TELA) OKs 3.5M-share incentive plan boost - Stock Titan
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesRevenue Recognition Risk - newsline.com
EW Healthcare Partners Fund 2-UGP Secures Board Seat at TELA Bio with 17.23% Stake - TradingView
EW Healthcare funds report 7.7M TELA Bio (TELA) shares and board seat - Stock Titan
TELA Bio Inc Annual Shareholders Meeting Transcript - GuruFocus
TELA Q1 2026 Earnings: EPS Miss Sends Stock Slightly LowerRevenue Inflection Point - newsline.com
TELA Bio Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesSurprise Factor Analysis - DonanımHaber
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):